Cargando…

The Notch1 gene may control cell chemoresistance in esophageal squamous cell cancer

BACKGROUND: In our previous study, missense mutations in the Notch1 gene were found in chemotherapy-resistant esophageal squamous cell cancer (ESCC) patients. In this study, we explored changes in the interaction between Notch1 and DLL4 resulting from missense mutations. METHODS: Bioinformatics anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Kun, Xing, Wenqun, Liu, Xianben, Liu, Jizhao, Sun, Haibo, Hao, Wentao, Zheng, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799163/ https://www.ncbi.nlm.nih.gov/pubmed/35116634 http://dx.doi.org/10.21037/tcr-21-447

Ejemplares similares

The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023)

Application of next-generation sequencing in resistance genes of neoadjuvant chemotherapy for esophageal cancer
por: Liu, Jizhao, et al.
Publicado: (2020)

Preemptive analgesia in the “non-tube no fasting” fast track program for resectable esophageal carcinoma
por: Liu, Xianben, et al.
Publicado: (2022)

Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma
por: Zheng, Yan, et al.
Publicado: (2020)

Relationship between postoperative complications of esophageal cancer surgery and season: a retrospective study
por: Liu, Xianben, et al.
Publicado: (2022)

The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
por: Zheng, Yan, et al.
Publicado: (2022)

Serum Fibrinogen Is An Independent Prognostic Factor In Operable Esophageal Squamous Carcinoma: A Real-World Study
por: Zheng, Yan, et al.
Publicado: (2019)

The feasibility of a “no tube, no fasting” fast-track recovery protocol after esophagectomy for esophageal cancer patients aged 75 and over
por: Xing, Wenqun, et al.
Publicado: (2023)

Treatment outcomes of surgery and chemotherapy for pulmonary metastases from non-lung cancers: a propensity score-matched analysis
por: Gao, Kun, et al.
Publicado: (2023)

Reevaluation of Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials Over the Past 20 Years
por: Zheng, Yan, et al.
Publicado: (2015)

THAP9-AS1/miR-133b/SOX4 positive feedback loop facilitates the progression of esophageal squamous cell carcinoma
por: Cheng, Jiwei, et al.
Publicado: (2021)

Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based Versus Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma
por: Zheng, Yan, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy Compared with Surgery for Oesophageal Carcinoma: A Retrospective Study and Missing Evidence
por: Zheng, Yan, et al.
Publicado: (2023)

The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study
por: Xing, Wenqun, et al.
Publicado: (2021)

A clinical nomogram for predicting tumor regression grade in esophageal squamous-cell carcinoma treated with immune neoadjuvant immunotherapy
por: Yu, Yongkui, et al.
Publicado: (2022)

A phase II, single-centre trial of neoadjuvant toripalimab plus chemotherapy in locally advanced esophageal squamous cell carcinoma
por: Xing, Wenqun, et al.
Publicado: (2020)

Silencing lncRNA AGAP2-AS1 Upregulates miR-195-5p to Repress Migration and Invasion of EC Cells via the Decrease of FOSL1 Expression
por: Shen, Sining, et al.
Publicado: (2020)

Neoadjuvant chemotherapy followed by minimally invasive esophagectomy versus primary surgery for management of esophageal carcinoma: a retrospective study
por: Zheng, Yan, et al.
Publicado: (2019)

HIPK3 Promotes Growth and Metastasis of Esophageal Squamous Cell Carcinoma via Regulation of miR-599/c-MYC Axis
por: Ba, Yufeng, et al.
Publicado: (2020)

GASC1 Promotes Stemness of Esophageal Squamous Cell Carcinoma via NOTCH1 Promoter Demethylation
por: Jia, Ruinuo, et al.
Publicado: (2019)

Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma
por: Liu, Aibin, et al.
Publicado: (2017)

Notch1 controls cell chemoresistance in small cell lung carcinoma cells
por: Hassan, Wael Abdo, et al.
Publicado: (2015)

Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma
por: Liu, Aibin, et al.
Publicado: (2021)

UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells
por: Zou, Jie, et al.
Publicado: (2013)

Salivary microbiota may predict the presence of esophageal squamous cell carcinoma
por: Wei, Junmin, et al.
Publicado: (2021)

Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor
por: HUANG, RUI, et al.
Publicado: (2015)

Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma
por: Zhang, Heng, et al.
Publicado: (2017)

Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma
por: Cheng, Caixia, et al.
Publicado: (2016)

MicroRNA-1 suppresses proliferation, migration and invasion by targeting Notch2 in esophageal squamous cell carcinoma
por: Liu, Wenzhi, et al.
Publicado: (2018)

MicroRNA‐338‐5p reverses chemoresistance and inhibits invasion of esophageal squamous cell carcinoma cells by targeting Id‐1
por: Han, Liang, et al.
Publicado: (2019)

Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma
por: Liu, Lizhen, et al.
Publicado: (2023)

Adjuvant radiotherapy, chemotherapy or surgery alone for high‐risk histological node negative esophageal squamous cell carcinoma: Protocol for a multicenter prospective randomized controlled trial
por: Guo, Xufeng, et al.
Publicado: (2018)

Identification of multidrug chemoresistant genes in head and neck squamous cell carcinoma cells
por: Khera, Neha, et al.
Publicado: (2023)

WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma
por: Abbaszadegan, Mohammad Reza, et al.
Publicado: (2018)

Feasibility of a single mediastinal drain through the abdominal wall after esophagectomy
por: Zheng, Yan, et al.
Publicado: (2018)

Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance
por: Che, Yun, et al.
Publicado: (2018)

Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma
por: Lin, Zheng, et al.
Publicado: (2022)

Survival based radiographic-grouping for esophageal squamous cell carcinoma may impact clinical T stage
por: Cai, Wenjie, et al.
Publicado: (2018)

Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma
por: Yang, Weixiong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dso0jsagsfc4c4qv0b8n50rh60